logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Antex Biologics, Inc.


USPTO Granted Patents = 18


Forward Citations = 116

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal John L Pace (11 out of 22 patents)

silverMedal Steven Michael Frey (9 out of 9 patents)

bronzeMedal Richard Ives Walker (9 out of 9 patents)

4.  W James Jackson (4 out of 12 patents)

5.  James E Samuel (3 out of 9 patents)

6.  Howard C Krivan (3 out of 7 patents)

7.  Andrea M Harris (2 out of 2 patents)

8.  Kenneth D Tucker (2 out of 11 patents)

9.  Laura Plosila (1 out of 5 patents)

10.  Ulrich F Tillman (1 out of 4 patents)

11.  Ulrich F Tillmann (1 out of 2 patents)

12.  Clifford A Lingwood (18 patents)

13.  Arne L Blomberg (1 patent)

14.  Kenneth Tucker (1 patent)

15.  Bo Nilsson (0 patent)


18 patents:

1. 6887843 - Chlamydia protein, gene sequence and uses thereof (2005-05-03),
2. 6756493 - Nucleic acid sequence and uses thereof (2004-06-29),
3. 6693186 - Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof (2004-02-17),
4. 6642023 - Chlamydia protein, gene sequence and uses thereof (2003-11-04),
5. 6541616 - Moraxella catarrhalis protein, gene sequence and uses thereof (2003-04-01),
6. 6214981 - Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof (2001-04-10),
7. 6083683 - Methods for detecting shigella bacteria or antibodies to shigella (2000-07-04),
8. 6077678 - Methods for detecting Campylobacter bacteria or antibodies to (2000-06-20),
9. 6051416 - Methods for producing enhanced antigenic Helicobacter sp. (2000-04-18),
10. 5976525 - Method for producing enhanced antigenic enteric bacteria (1999-11-02),
11. 5897475 - Vaccines comprising enhanced antigenic helicobacter spp. (1999-04-27),
12. 5869066 - Vaccine containing a campylobacter bacterium having an enhanced (1999-02-09),
13. 5858352 - Vaccine containing a Shigella bacterium having an enhanced antigenic (1999-01-12),
14. 5843463 - Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae (1998-12-01),
15. 5721115 - DNA encoding a novel Haemophilus influenzae protein (1998-02-24),
Company Overview
Antex Biologics, Inc. is a biotechnology company based in Gaithersburg, Maryland, specializing in the development of innovative therapeutics and vaccines. The organization focuses on addressing unmet medical needs through advanced research in immunology and infectious diseases. Antex leverages cutting-edge technologies to create solutions that enhance patient outcomes and contribute to global health advancements. Their commitment to scientific excellence positions them as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

18 Patents

#23 in Gaithersburg, MD

#246 in Maryland

#17,963 in US

#34,217 in the World

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America

Antex Biologics, Inc.

Forward Citations = 116

11 inventors:

goldMedal John L Pace (11 out of 22 patents)

silverMedal Steven Michael Frey (9 out of 9 patents)

bronzeMedal Richard Ives Walker (9 out of 9 patents)

4.  W James Jackson (4 out of 12 patents)

5.  James E Samuel (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Antex Biologics, Inc.. Retrieved from https://idiyas.com/company/antex-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…